Twitter

Posts Tagged ‘san’


Skin Cancer Awareness by Dr. Melanie Palm, UT-TV San Diego

Dermatologist and cosmetic surgeon Dr. Melanie Palm of www.artofskinmd.com speaks with UT-TV San Diego news anchor Taylor Baldwin about Melanoma awareness mo…

Read More...

Cancer Metastasis Promoted By Tumor-Activated Protein

Researchers at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center report that cancers physically alter cells in the lymphatic system – a network of vessels that transports and stores immune cells throughout the body – to promote the spread of disease, a process called metastasis…

Read More...

Study Assesses Outcomes Of Prostate-Specific Antigen Screening Among Older Men

A new study has examined the outcomes of an abnormal prostate-specific antigen (PSA) screening result of 4.0 ng/mL or more among men over the age of 65. The study, led by Louise C. Walter, M.D., of San Francisco Veterans Affairs Medical Center, included a total of 295,645 men 65 years or older who underwent PSA screening in 2003. The participants were followed up for a total of five years…

Read More...

Study Assesses Outcomes Of Prostate-Specific Antigen Screening Among Older Men

A new study has examined the outcomes of an abnormal prostate-specific antigen (PSA) screening result of 4.0 ng/mL or more among men over the age of 65. The study, led by Louise C. Walter, M.D., of San Francisco Veterans Affairs Medical Center, included a total of 295,645 men 65 years or older who underwent PSA screening in 2003. The participants were followed up for a total of five years…

Read More...

Engineered small pox may kill liver cancer

As part of a multicenter clinical trial, researchers at University of California, San Diego School of Medicine are evaluating Pexa-Vec (JX-594) to slow the progression of hepatocellular carcinoma or liver cancer. Pexa-Vec is a genetically engineered virus that is used in the smallpox vaccine.

Read More...

New Brain Cancer Treatment is More Effective, Less Toxic

A Phase 2 clinical trial testing a new protocol for treating a relatively rare form of brain cancer, primary CNS lymphoma, may change the standard of care for this disease, according to doctors at UC San Francisco who led the research.

Read More...

New Brain Cancer Treatment is More Effective, Less Toxic

A Phase 2 clinical trial testing a new protocol for treating a relatively rare form of brain cancer, primary CNS lymphoma, may change the standard of care for this disease, according to doctors at UC San Francisco who led the research.

Read More...

Will cell therapy become a ‘third pillar’ of medicine?

Treating patients with cells may one day become as common as it is now to treat the sick with drugs made from engineered proteins, antibodies or smaller chemicals, according to UC San Francisco researchers. They have outlined their vision of cell-based therapeutics as a “third pillar of medicine.”

Read More...

Esophageal cancer risk may be reduced through a variety of lifestyle factors — from taking aspirin to losing belly fat

Fred Hutchinson Cancer Research Center is home to the Seattle Barrett’s Esophagus Program, a multidisciplinary effort conducted in collaboration with researchers at Brigham & Women’s College and the University of California at San Francisco. This research team has shown that a systematic approach to early cancer detection can boost five-year survival rates from about 15 percent to more than 80 percent.

Read More...

Researchers Aim Unlock Genetic Data Goldmine

Researchers in the San Francisco Bay area believe genetic tests will help them find the best ways to treat and potentially prevent diseases such as Alzheimer’s disease, breast and prostate cancers. Spencer Michels reports on a giant data bank that houses genetic information on 200000 people as part of a groundbreaking study.

Read More...